Posts
NASHP Partners with Mathematica to Strengthen State Rx Transparency Laws
/in Policy Blogs Prescription Drug Pricing /by NASHP WritersThe National Academy for State Health Policy (NASHP) is partnering with Mathematica Policy Research to help states increase transparency and accountability to address rising prescription drug prices. This state-directed partnership will support the alignment of data collection and enable cross-state analyses. Currently, California, Oregon, Nevada, Connecticut, and Vermont require manufacturers to report on price increases and the reasons behind those increases. Maine and New Hampshire are conducting studies on drug price transparency.
The results of this initiative — Supporting Effective State Transparency Laws — will become available for use by all states in 2019 through funding support by the Laura and John Arnold Foundation. The results will include:
- A common prescription drug pricing data set that states agree should be collected;
- Optional data elements states may collect, based on specific legislative goals;
- A roadmap for implementing transparency legislation, including reporting protocols, quality control, and data sources;
- A template for a searchable database that states can adapt for their own use, which will facilitate cross-state analyses; and
- Updated model state transparency legislation.
Mathematica was selected following a competitive bidding process. NASHP received a dozen proposals that were reviewed by State Transparency Implementation Network officials. Mathematica’s expertise in data collection and data integrity enable them be effective partners with NASHP in identifying and meeting states’ needs as they design and implement effective transparency legislation.
Aligning efforts across states through uniform data collection will help all states collect solid data on the extent and drivers behind rising drug prices. High-quality data will ultimately help states achieve better understanding of price increases and empower them to take effective action to control them.
Learn more at NASHP’s Center for State Rx Drug Pricing.
Sign Up for Our Weekly Newsletter
Sign Up for Our Weekly Newsletter
Washington, DC Office:
1233 20th St., N.W., Suite 303Washington, DC 20036
p: (202) 903-0101
f: (202) 903-2790
Contact Us
Phone: 202-903-0101

For individuals living with complex, often chronic conditions, and their families, palliative care can provide relief from symptoms, improve satisfaction and outcomes, and help address critical mental and spiritual needs during difficult times. Now more than ever, there is growing recognition of the importance of palliative care services for individuals with serious illness, such as advance care planning, pain and symptom management, care coordination, and team-based, multi-disciplinary support. These services can help patients and families cope with the symptoms and stressors of disease, better anticipate and avoid crises, and reduce unnecessary and/or unwanted care. While this model is grounded in evidence that demonstrates improved quality of life, better outcomes, and reduced cost for patients, only a fraction of individuals who could benefit from palliative care receive it. 























































































































































